SPHK1 and preeclampsia: Collectively these data provide further support to the notion that SPHK1 and angiogenic S1PR1 and -3 receptors pathway is impaired in term human placentae from PE patients and might be responsible for impaired vasculogenesis/angiogenesis observed during preeclampsia.